In an experiment published in Cloning & Stem Cells, scientists from International Stem Cell (ISC) Corp. derived four unique embryonic stem cell lines that open the door for the creation of therapeutic cells that will not provoke an immune reaction in large segments of the population. The stem cell lines are “HLA-homozygous,” meaning that they have a simple genetic profile in the critical areas of the DNA that code for immune rejection.
read more
Stem cells: Bush’s shameful first veto?Skin Cell to Stem Cell News Is No SurpriseExcel 2003 - Can’t Insert Picture Into Cell ?!?Researchers Work on Cocaine VaccineNext-Gen Asus Eee PC Packs WiMax, 8.9-Inch Screen